News

AI powered companion diagnostics reshaping the future of precision medicine.

Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026

HALO AP, News, Press Releases / , ,

Albuquerque, NM, May 27, 2026 – Indica Labs, the global leader in AI-powered digital pathology solutions, today announced a major expansion of its companion diagnostics (CDx) capabilities, positioning the company at the forefront of precision medicine innovation ahead of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

Indica Labs Unveils AI-Powered Companion Diagnostics Offering Ahead of ASCO 2026 Read More »

A partnership Leica Biosystems, Indica Labs, and Lunit that will focus on PD-L1 and emerging immunohistochemistry (IHC) biomarkers, supporting scalable and consistent biomarker quantification through computational pathology tools. The first product is an AI-powered Lunit SCOPE algorithm designed for Leica Biosystems’ PD-L1 primary antibody (CAL10).

Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers

HALO AP, News, Press Releases /

VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in AI-powered digital pathology software, today announced a strategic collaboration with Lunit (KRX:328130.KQ), a leading provider of AI solutions for cancer diagnostics and therapeutics, to develop AI-powered image analysis algorithms. The partnership will focus on PD-L1 and emerging immunohistochemistry (IHC) biomarkers, supporting scalable and consistent biomarker quantification through computational pathology tools. The first product is an AI-powered Lunit SCOPE algorithm designed for Leica Biosystems’ PD-L1 primary antibody (CAL10). The new algorithm, Lunit SCOPE PD-L1 CAL10 NSCLC1, is now available through Leica Biosystems’ Aperio AI Store.

Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers Read More »

Leica Biosystem and Indica Labs combined Aperio HALO AP DX and Aperio GT 450 DX Scanner for a complete clinical digital pathology ecosystem

Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch

HALO AP, HALO AP Dx, News, Press Releases / , , ,

Vista, CA, and Albuquerque, NM, March 31, 2026 – Leica Biosystems, a Danaher company and a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, launches Aperio HALO AP DX image management system designed for use with the Aperio GT 450 DX scanner. Together, the Aperio HALO AP DX software and the Aperio GT 450 DX scanner provide a complete, integrated clinical digital pathology solution supporting on‑screen diagnostics across routine pathology workflows in the USA.

Leica Biosystems and Indica Labs Expand Digital Pathology-Powered Diagnostics in the USA with Aperio HALO AP DX Software Launch Read More »

A lap top looking over the Sandia mountains in Albuquerque, NM; showcasing an IHC breast tissue image on the lap top screen with HER2 3+ stanning. Using AI and digital pathology for precision medicine, anytime anywhere.

AI and Digital Pathology in Personalized Medicine: The Past, Present, and Future of Breast Cancer Care

Blogs, Breast IHC AI, HALO AP, News / , , , , ,

AI-powered digital pathology is redefining modern cancer care by extending clinical-grade insights beyond the microscope and enabling standardized, pixel-level analysis to support scalable cancer diagnostics anytime, anywhere.

AI and Digital Pathology in Personalized Medicine: The Past, Present, and Future of Breast Cancer Care Read More »

Free Demo
Free Demo
Scroll to Top